Olympus reported its first-quarter results for the fiscal year ending March 2027, with operating profit jumping 74.4% year-on-year to 29 billion yen and profit attributable to owners of the parent more than doubling to 19.1 billion yen. The company also raised its full-year operating profit forecast to 146 billion yen from the previous 136.5 billion yen, and its net profit forecast to 102.3 billion yen. This represents a roughly 50% increase from the prior year's operating profit of 97.1 billion yen. Following the announcement, shares surged at the start of the week, climbing 10% from the previous close to 2,099 yen, marking a gain of over 20% from the recent one-month low. While the first-quarter operating profit accounts for about 20% of the full-year forecast, the medical device business is typically weighted toward the second half, so progress is seen as solid, and the market welcomed the company's confidence in a full-year recovery.
Olympus Corp.Q1 operating profit surged 74% and full-year guidance raised, driving shares up 10%.
